Related references
Note: Only part of the references are listed.A cost-effectiveness threshold based on the marginal returns of cardiovascular hospital spending
Pieter van Baal et al.
HEALTH ECONOMICS (2019)
Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands
V. T. Reckers-Droog et al.
HEALTH POLICY (2018)
Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-51, in evaluating drug therapies for rheumatoid arthritis
Monica Hernandez-Alava et al.
JOURNAL OF HEALTH ECONOMICS (2017)
Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss
Ulrikke J. V. Hernaes et al.
PHARMACOECONOMICS (2017)
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A Country Adaptation Analysis Under the Former and Current Dutch Pharmacoeconomic Guidelines
Isaac Corro Ramos et al.
VALUE IN HEALTH (2017)
A new proposal for priority setting in Norway: Open and fair
Trygve Ottersen et al.
HEALTH POLICY (2016)
Dutch Tariff for the Five-Level Version of EQ-5D
Matthijs M. Versteegh et al.
VALUE IN HEALTH (2016)
Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALY
Erik Nord et al.
HEALTH POLICY (2014)
Some Inconsistencies in NICE's Consideration of Social Values
Mike Paulden et al.
PHARMACOECONOMICS (2014)
Guidance on priority setting in health care (GPS-Health): the inclusion of equity criteria not captured by cost-effectiveness analysis
Ole F. Norheim et al.
COST EFFECTIVENESS AND RESOURCE ALLOCATION (2014)
Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfall
E. J. van de Wetering et al.
EUROPEAN JOURNAL OF HEALTH ECONOMICS (2013)
Inquiry into the Relationship between Equity Weights and the Value of the QALY
Ana Bobinac et al.
VALUE IN HEALTH (2012)
DISCOUNTING AND DECISION MAKING IN THE ECONOMIC EVALUATION OF HEALTH-CARE TECHNOLOGIES
Karl Claxton et al.
HEALTH ECONOMICS (2011)
Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)
M. Herdman et al.
QUALITY OF LIFE RESEARCH (2011)
Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets
Richard Heijink et al.
POPULATION HEALTH METRICS (2011)
Severity of illness and priority setting in healthcare: A review of the literature
Koonal K. Shah
HEALTH POLICY (2009)
Weighting Must Wait Incorporating Equity Concerns into Cost-Effectiveness Analysis May Take Longer than Expected
Allan Wailoo et al.
PHARMACOECONOMICS (2009)
Share Paper
